Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
CPT 96401: Subcutaneous or Intramuscular Nonhormonal Chemotherapy
CPT-96402-SUBCUTANEOUS-INTRAMUSCULAR-HORMONAL-ANTINEOPLASTIC-ADMINISTRATIONCPT 96402: Subcutaneous/Intramuscular Hormonal Anti‑Neoplastic Administration
CPT-96405-INTRALESIONAL-CHEMOTHERAPY-ONE-TO-SEVEN-LESIONSCPT 96405: Intralesional Chemotherapy, 1–7 Lesions
CPT-96406-INTRALESIONAL-CHEMOTHERAPY-MORE-THAN-7-LESIONSCPT 96406: Intralesional Chemotherapy for >7 Lesions
CPT-96409-INTRAVENOUS-PUSH-CHEMOTHERAPY-INITIAL-DRUGCPT 96409: Intravenous Push Chemotherapy, Single/Initial Drug
CPT-96411-ADD-ON-INTRAVENOUS-PUSH-CHEMOTHERAPY-DRUGCPT 96411: Add-On IV Push for Additional Chemotherapy Drug
CPT-96413-INTRAVENOUS-CHEMOTHERAPY-INFUSION-INITIAL-HOURCPT 96413: Intravenous Chemotherapy Infusion, Initial Hour
CPT-96415-ADDITIONAL-HOUR-CHEMOTHERAPY-INTRAVENOUS-INFUSIONCPT 96415: Continued Intravenous Chemotherapy Infusion, Per Additional Hour
CPT-96416-CHEMOTHERAPY-INITIATION-PORTABLE-IMPLANTABLE-PUMPCPT 96416: Initiation of Intravenous Chemotherapy via Pump
CPT-96417-ADD-ON-IV-CHEMOTHERAPY-INFUSION-DIFFERENT-AGENTCPT 96417: Continued Intravenous Chemotherapy Administration
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.